The c-AMP dependent protein kinase (PKA) inhibition, haemolytic activity, and cytoxicity of 21 extracts obtained from North Western Australian sponges collected from depths of 84-135 m were investigated. Hexane extracts from Ircinia/Sarcotragus sp. and Geodia sp. displayed PKA inhibitory activities of 100 and 97% respectively (at 100 μg/mL), while aq. methanol extracts from Haliclona sp. exhibited potent haemolytic activity (75%) and hexane extracts from Geodia sp. were highly toxic (88%) to the brine shrimp Artemia franciscana. As the non-polar extracts gave the greatest PKA inhibition, these were further analysed by GC-MS and 29 fatty acids were identified in the highest proportions in Ircinia/Sarcotragus sp. > Haliclona sp. > Geodia sp. In contrast to shallow-water sponges that are dominated by polyunsaturated fatty acids with a high percentage of long chain fatty acids, LCFAs (C 24 -C 30 ), the deep-sea sponges investigated herein were all found to be rich in saturated fatty acids, in particular C 14 -C 20 fatty acids, including odd and branched chain fatty acids, with only low levels (0-10%) of LCFAs. Screening of the PKA inhibitory activity of a series of commercially available fatty acids identified C 14 -C 18 fatty acids as possessing significant PKA inhibitory activity that may contribute to the activity observed in the sponges studied.
The deep sea is one of the most biodiverse and species-rich habitats on the planet, but also one of the least explored. In recent years, deep-sea organisms have emerged as an important new source of unexplored chemical, genetic and biological diversity [1a] . Yet of the 30,000 marine natural products reported to-date, less than 2% derive from deepsea organisms [1b] . Moreover, metabolites from deep-sea organisms have exhibited a significantly higher 'hit rate' than their shallow-water counterparts in a wide number of bioassays [1c] , including cytotoxicity towards both murine and human cancer cell lines [1b,2] . Of particular interest, are the metabolites from deep-sea sponges, which account for over 60% of the deep-sea natural products reported [1b] .
c-AMP Dependent protein kinase (protein kinase A, PKA) is an important enzyme involved in the regulation of an increasing number of physiological processes including immune, cardiovascular and reproductive functions; steroid biosynthesis; adipocyte metabolism; and exocytotic processes [3a] . As such, the inhibition of PKA has become an attractive drug target in a number of areas, in particular in immune function [3b] and for memory disorders such as Alzheimer's and Parkinson's disease and schizophrenia [3c] . Interestingly, despite PKA being one of the most well characterized of all protein kinases [3d], there are as yet no PKA inhibitors reported from any marine sources [4] . In addition to screening for specific enzyme inhibitors, the brine shrimp lethality assay is a simple and inexpensive way to screen natural product extracts for pharmacological activity [5a] . A strong correlation has been found between brine shrimp toxicity and cytotoxicity in human cancer cell lines [5b] , and cytotoxicity is the most commonly reported biological activity in marine fauna, in particular marine sponges [5c]. Haemolytic activity is also prevalent in Porifera, and is another general indicator of bioactivity, in particular membrane-directed cytotoxicity, which is desirable in the development of bactericidal molecules and for targeted intracellular drug delivery.
Herein, we describe the biological screening of 21 extracts obtained from three NW Australian deep-sea sponge samples. The sponge extracts described herein were tested for their ability to inhibit PKA; to lyse equine erythrocytes; and for their toxicity towards the brine shrimp Artemia francescana. Furthermore, the fatty acid composition of the bioactive, non-polar extracts of each sample was identified by GC-MS. Using remotely operated vehicles, a range of deep-sea organisms including sponges, cnidarians, echinoderms, crustaceans and fish were NPC Natural Product Communications [6a,6b] . From this diverse collection, the three largest sponge samples were chosen for investigation and identified as Haliclona sp. (Order Haplosclerida, Family Chalinidae), Geodia sp. (Order Astrophorida, Family Geodiidae) and an intertwined sample of Sarcotragus sp. and Ircinia sp. (both belonging to the Order Dictyoceratida, Family Irciniidae). Crude extracts were prepared from each sample with dichloromethane and methanol and further partitioned using a modified Kupchan method to give seven partially purified extracts in water, butanol, 50% aq. methanol, 10% aq. methanol, dichloromethane and two hexane extracts, one from the original crude methanol extract (referred to as hexane 1) and the other from the original dichloromethane extract (referred to as hexane 2). This gave a total of 21 extracts that were tested at a final concentration of 100 g/mL.
PKA inhibitory activity of 97-100% was observed for the hexane 1 extracts of all sponges investigated except Haliclona. Other non-polar extracts, including the hexane 2 from Geodia sp. and the dichloromethane extract from Iricinia/Sarcotragus sp. displayed significant activity (41-84%, Fig. 1 A-C). This is consistent with the large number of non-polar kinase inhibitors described from marine sponges, which include sesterterpenoid mitogen activated protein kinase MSK1 and MAPKAPK-2 inhibitors from Ircinia sp. [7a] and a series of prenylhydroquinones isolated from Sarcotragus muscarum and Ircinia fasciculata that inhibited multiple protein kinases [7b] . Although marine-derived PKA inhibitors are yet to be reported, PKA and related enzymes have been identified from marine sources (mollusks, microalgae), where they play similar roles to their mammalian counterparts [7c].
Haemolytic activity was found in over half of the extracts, with the greatest activity (75%) observed for the 50% aq. methanol extract of the Haliclona sp. Extracts showing the highest PKA inhibitory activity ( Figure 1 , hexane 1 panels B-C) displayed low haemolysis, while almost all Haliclona extracts exhibited significant haemolytic activity (Figure 1 , panel D), consistent with reports of such activity for this genus [8] . Of the sponges under investigation, haemolytic activity has previously been reported for both Haliclona sp. and Geodia corticostylifera [9a] . The hexane 1 extract from Geodia sp. exhibited 88% toxicity towards the brine shrimp A. franciscana; the first report of such activity for this genus (see Supplementary data). Although not observed here, brine shrimp toxicity has been reported previously for the other two sponge genera studied here, including a family of cerebrosides from Haliclona sp.
[9b] and three sulphated polyprenylhydroquinones from Ircinia spinosula [9c] .
A diverse range of bioactive metabolites have been reported from shallow-water species from the four sponge genera under investigation. There is, however, a paucity of reported metabolites from related deep-water species, with only a small handful to-date including: triterpenoids [10a] GC-MS analysis on the lipid component of each sponge was performed (see Table 1 ), and a total of 23 fatty acids identified for the Haliclona sp. as 23-67% of each extract. The major fatty acids were the PUFA C20:4 n-5 (21%) and 9-octadecenoic acid (7%) in the hexane 1 extract; hexadecanoic acid (8%) and 12-methyltetradecanoic acid (6%) in the hexane 2 extract; and 3-methylbutanoic acid (14%) and eicosanoic acid (7%) in the dichloromethane extract.
A total of 17 fatty acids were identified for the Geodia sp. as 4-24% of each extract: significantly lower than in the other sponges. The C18 fatty acids, 9-octadecenoic acid (5%) and octadecanoic acid (5%) in the dichloromethane extract were the most abundant fatty acids in this sponge, with all other fatty acids present as <5% of each extract. In contrast, the Ircinia/Sarcotragus sp. were particularly rich in fatty acids, with a total of 22 identified as 42-83% of each extract. The major fatty acids, accounting for 10% of each extract, were 7-methylhexadecanoic acid/PUFA C20:4 n-5, 11-octadecenoic acid, and octadecanoic acid in the hexane 1, hexane 2 and dichloromethane extracts.
A diverse range of fatty acids were identified for the deepsea sponges including long, branched and odd chain fatty acids common to the phylum Porifera [11a] . The fatty acid profile was dominated by saturated C 14 -C 20 fatty acids, but also varied across species either in type or in relative percentages, including extracts exhibiting similar activities. There were no apparent correlations amongst the bioassay results and/or their lipid profiles. For example, although the bioactivity profiles of the Geodia and Ircinia/
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Natural Product Communications Vol. 6 (12) 2011 1923 Sarcotragus species were similar, their fatty acid profiles were entirely different. For the latter, even extracts displaying similar PKA inhibition activities comprised entirely different fatty acids (cf. the Ircinia hexane 1 and dichloromethane extracts in Figure 1 , panel C and Table 1 , columns B and C). Likewise, two of the samples obtained from the identical location and depth (Geodia and Haliclona) displayed both different bioactivities and fatty acid profiles, indicating that these attributes are largely species dependent. Of the sponge genera investigated, only the fatty acid composition for Ircinia sp. has been reported in detail previously, which showed a similar predominance of straight and branched C 14 -C 18 fatty acids to that obtained. Our Ircinia/Sarcotragus sp. from 84 m depth contained a greater proportion of saturated fatty acids than reported Ircinia specimens from ~10 m, and also lacked the C 24 -C 25 Δ 5,9 demospongic acids characteristic of shallow-water Ircinia sp. [11b] . However, whether these differences are depth related will require further study.
To test which of the fatty acids may contribute to the observed bioactivity, a series of commercially available fatty acids (C14:0, C16:0, C18:0, C18:1, C14-22, C18-22) were examined for their ability to inhibit PKA. Several of these exhibited high levels of PKA inhibition at 100 µg/mL in the order C14:0 (64%), C16:0 (34%), C18:1 (33%) and C18:0 (26%) (see Supplementary data). As these are the dominant fatty acids in the sponges investigated, they may contribute to the observed PKA inhibitory activities, along with other non-polar metabolites, the identification of which is currently underway. In conclusion, these results indicate that deepsea sponges of NW Australia are a rich source of PKA inhibitory, haemolytic and cytotoxic substances.
Experimental

Collection:
The deep-sea sponges, were collected in the North West Shelf of Australia in June-August of 2008 and identified as: Haliclona sp., Geodia sp., and a mixed sample of intertwined Sarcotragus sp. and Ircinia sp., the former two from the same location (depth 135 m), and the latter from a location 80 km away (depth 84 m). Samples were collected under permit AU-COM2008032 issued by the Australian Government and vouchers (WAMZ45792-WAMZ45795) are at the Western Australian Museum.
Extracts: Sponge extracts were prepared from methanol and dichloromethane, followed by fractionation using a modified Kupchan partitioning method [12] to give seven extracts: water, butanol, 50% aq. methanol, 10% aq. methanol, dichloromethane, hexane (1) and hexane (2) , where hexane (1) was derived from the crude methanol extract and hexane (2) from the crude dichloromethane extract (see Supplementary data). All assays were conducted at 100 µg/mL (in 2% DMSO or 2% ethanol).
Protein kinase A inhibition:
This was determined using the Kinase-Glo ® Luminescent Kinase Assay (Promega Corporation, Madison, USA). Each well of an opaque white 96 well plate (Corning) contained 5 µL of sample, 25 µL of ATP (20 µM), and 20 µL of a mixture of kinase (0.1unit/µL) and Kemptide substrate (140 µM) in reaction buffer (40 mM Tris, 20mM MgCl 2 , BSA 0.1mg/mL, pH 7.4). After incubation (1 h, rt), 50 µL of the Kinase-Glo ® Reagent was added, the mixture incubated for 15 min and luminescence measured using a BMG Labtech FLUOstar Optima ® luminometer. Data were determined relative to positive controls containing only solvent, while negative controls contained no substrate and staurosporine (IC 50 = 7nM against PKA) was used as an internal standard.
